CDD-2789

CAT: 0931-T206617-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-T206617-01Size:10 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
3052084-77-9
Target
TGF-beta/Smad|||ALK
Related Pathways
Angiogenesis|||Stem Cells|||Tyrosine Kinase/Adaptors
Bioactivity
CDD-2789 is a highly selective small molecule inhibitor that targets Activin receptor type 1 (ALK2, also known as ACVR1) . It effectively blocks the BMP and activin A-induced downstream phosphorylation reactions by inhibiting the ALK2/ALK1-mediated SMAD1/5 signaling pathway. In the NanoBRET cell model, CDD-2789 demonstrates an inhibitory activity with an IC50 value of 0.54 µM for ALK2. This compound holds potential for research in ALK2-related diseases, including brainstem glioma (DIPG), ependymoma, endometrial cancer, melanoma, non-small cell lung cancer, colorectal cancer, and pancreatic cancer.
Smiles
O=C(NCCCN(C)C)C1=CC=C2N=C(C=3C=C(OC)C(OC)=C(OC)C3)N(C2=C1)C4CCC4
Molecular Formula
C26H34N4O4
Molecular Weight
466.573
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Popular Products